These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10872850)

  • 1. Trillium biopassive surface: a new biocompatible treatment for extracorporeal circulation circuits.
    Cazzaniga A; Ranucci M; Isgrò G; Soro G; De Benedetti D; Corradi R; Gardinali M
    Int J Artif Organs; 2000 May; 23(5):319-24. PubMed ID: 10872850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trillium-coated oxygenators in adult open-heart surgery: a prospective randomized trial.
    Dickinson T; Mahoney CB; Simmons M; Marison A; Polanski P
    J Extra Corpor Technol; 2002 Dec; 34(4):248-53. PubMed ID: 12533060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
    Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
    Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
    Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Trillium Biopassive Surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass.
    Palanzo DA; Zarro DL; Montesano RM; Manley NJ; Quinn M; Elmore BA; Gustafson PA; Castagna JM
    Perfusion; 1999 Nov; 14(6):473-9. PubMed ID: 10585155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
    van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility.
    Tevaearai HT; Mueller XM; Seigneul I; Burki M; Horisberger J; Stumpe F; Von Segesser LK
    Int J Artif Organs; 1999 Sep; 22(9):629-34. PubMed ID: 10532432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation.
    de Vroege R; Rutten PM; Kalkman C; Out TA; Jansen PG; Eijsman L; de Mol BJ; Wildevuur CR
    Perfusion; 1997 Nov; 12(6):369-75. PubMed ID: 9413849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators.
    Zimmermann AK; Weber N; Aebert H; Ziemer G; Wendel HP
    J Biomed Mater Res B Appl Biomater; 2007 Feb; 80(2):433-9. PubMed ID: 16850460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits.
    Gunaydin S; Farsak B; Kocakulak M; Sari T; Yorgancioglu C; Zorlutuna Y
    Ann Thorac Surg; 2002 Sep; 74(3):819-24. PubMed ID: 12238845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
    Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
    Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.